Martin Currie’s Elevance Health ELV Stock Holding History

Martin Currie’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7	Closed	-$2K	–	93
2018 Q4	$2K	Hold	7	–	–	﹤0.01%	88
2018 Q3	$2K	Hold	7	–	–	﹤0.01%	96
2018 Q2	$2K	Sell	7 -6	-46%	-$1.39K	﹤0.01%	95
2018 Q1	$3K	Sell	13 -46,827	-100%	-$11M	﹤0.01%	104
2017 Q4	$10.5M	Sell	46,840 -6,160	-12%	-$1.31M	0.74%	35
2017 Q3	$10.1M	Buy	53,000 +1,400	+3%	+$266K	0.77%	42
2017 Q2	$9.71M	Hold	51,600	–	–	0.78%	43
2017 Q1	$8.53M	Buy	+51,600	New	+$8.21M	0.7%	48
2015 Q2	–	Sell	-41,661	Closed	-$6.43M	–	92
2015 Q1	$6.43M	Hold	41,661	–	–	0.58%	53
2014 Q4	$5.24M	Buy	41,661 +1,400	+3%	+$173K	0.45%	60
2014 Q3	$4.82M	Hold	40,261	–	–	0.41%	59
2014 Q2	$4.33M	Sell	40,261 -19,900	-33%	-$2.05M	0.38%	62
2014 Q1	$5.99M	Sell	60,161 -73,639	-55%	-$6.66M	0.55%	51
2013 Q4	$12.4M	Sell	133,800 -33,300	-20%	-$2.96M	1.14%	35
2013 Q3	$14M	Sell	167,100 -34,200	-17%	-$2.93M	1.5%	26
2013 Q2	$16.5M	Buy	+201,300	New	+$15.1M	1.79%	21

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Martin Currie's ELV Position: Q1 2019 in Review

Martin Currie sold out of Elevance Health (ELV) in Q1 2019, closing a stake of 7 shares — an estimated $2K sold.

Martin Currie first reported a position in ELV in Q2 2013 and held it in 16 quarters. The position peaked at $16.5M in Q2 2013. 1,076 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

Martin Currie reported no remaining Elevance Health position as of Q1 2019 after selling out during the quarter.
Martin Currie sold 7 Elevance Health shares in Q1 2019, an estimated $2K.
Martin Currie first reported a position in Elevance Health in Q2 2013 and held it in 16 quarters.
Martin Currie's Elevance Health position peaked at $16.5M in Q2 2013.
1,076 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Martin Currie's 13F filing for Q1 2019, filed 15 May 2019.